2026

CDMO division has successfully completed Stage 1 under a development contract Vancouver, British Columbia and Rehovot, Israel – March 31, 2026 — BioHarvest Sciences Inc. (“BioHarvest” or the “Company”), (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has successfully completed Stage 1 […]

FY2025 Revenues were $34.5 million,  up 37% vs previous year. The VINIA brand has achieved the  No.1 resveratrol polyphenol position in the United States Market*. Successful 4Q2025 Institutional-led Financing raised gross proceeds of an oversubscribed  $19.9 million. Cash and cash equivalents of $23 million as of December 31, 2025. Vancouver, British Columbia and Rehovot, Israel

Vancouver, British Columbia and Rehovot, Israel – March 5, 2026 – BioHarvest Sciences Inc. (NASDAQ: BHST) (“BioHarvest” or the “Company”), a leader in Botanical Synthesis technology, today announced that Mr. David Tsur will step down from its Board of Directors after more than four years of service. The Company further announced the appointment of Prof.

Vancouver, British Columbia and Rehovot, Israel – March 3, 2025 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 38th Annual Roth Conference taking place on March 22-24, 2026. CEO Ilan Sobel is scheduled to

Vancouver, British Columbia and Rehovot, Israel – January 7, 2026– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2025 marked an important milestone for BioHarvest Sciences: our first full